Cooperative Major in Advanced Biomedical Sciences, Joint Graduate School of Tokyo Women's Medical University and Waseda University, Waseda University, 2-2 Wakamatsucho, Shinjuku, Tokyo, 162-8480, Japan.
Institute for Medical Regulatory Science, Waseda University, Tokyo, Japan.
J Artif Organs. 2022 Dec;25(4):350-359. doi: 10.1007/s10047-022-01317-4. Epub 2022 Mar 3.
The Stanford Biodesign program was first introduced in Japan in 2015 at three national universities to develop medical technology innovation and its talent. This study aimed to (1) show the outcomes of leadership talent development, (2) indicate the educational results of the program, and (3) objectively analyze the ways in which the program executed in Japan, effectively promoted entrepreneurship orientation and the origination of new businesses. The latter is especially relevant as Japan has low entrepreneurial awareness and new business entry rates compared to the United States and Europe. Herein, fellows were subjected to questionnaires, interviews, and a survey based on academic papers, extant literature, and treatises issued by the Nihon Biodesign Gakkai (Academic Society of Japan Biodesign). Overall program performance showed notable results, despite indicating a need to improve business-related programs and team learning which is greatly influenced by Japanese culture. An externship program, planned and developed in Japan, was most inspiring and served to expose participants to role models. Comparing Japan Biodesign education elements to factors of general entrepreneurship promotion in Japan, sampled and organized from relevant White Papers, proved its educational effectiveness in entrepreneurship promotion from an objective viewpoint. Within the 4-year timeframe, the results indicated that leadership talent was indeed developed. Medical device innovation should progress through the stages of establishing new ventures, followed by contriving medical devices with novel, impactful value. This study revealed that Japan Biodesign education provides a platform for achieving these goals, despite the challenging Japanese new business environment.
斯坦福 Biodesign 计划于 2015 年首次在日本的三所国立大学推出，旨在发展医学技术创新及其人才。本研究旨在：(1)展示领导力人才培养的成果；(2)展示该计划的教育成果；(3)客观分析该计划在日本的执行方式，有效促进创业导向和新业务的产生。这一点尤其重要，因为与美国和欧洲相比，日本的创业意识和新企业进入率较低。在此，研究员们接受了问卷调查、访谈，并基于学术论文、现有文献和日本 Biodesign 学会（Nihon Biodesign Gakkai）发布的论文进行了调查。尽管表明需要改进与商业相关的课程和受日本文化影响较大的团队学习，但总体计划表现出了显著的成果。在日本计划和开发的实习计划最具启发性，使参与者能够接触到榜样。将日本 Biodesign 教育元素与从相关白皮书抽样并组织的日本一般创业促进因素进行比较，从客观角度证明了其在创业促进方面的教育效果。在 4 年的时间内，结果表明领导力人才确实得到了培养。医疗器械创新应通过建立新企业的阶段推进，然后构思具有新颖、有影响力价值的医疗器械。本研究表明，尽管日本新的商业环境具有挑战性，但日本 Biodesign 教育提供了实现这些目标的平台。
